Wednesday, February 27, 2019

Merck Launches Cutting Edge Fertility Technologies in India

Merck, a leading science and technology company, launched its cutting-edge fertility technology in India today. The business launched two devices, namely Geri and Gavi, as well as Gems, a complete culture medium suite. This will be made available in partnership with Genea Biomedx, to IVF clinics and hospitals.

This new technology provides an environment that helps to reduce external stresses on the embryos of patients undergoing fertility treatment. Individually-controlled chambers allow the embryos of each patient to grow separately and real-time cameras attached to each chamber reduces the frequency of opening and closing the chambers in Geri. Not only does this allow observation of the progress of embryo growth without removing the embryo from the chamber, it also reduces the impact on the embryo of factors such as changes in gas concentration and temperature.

“Merck has a market-leading portfolio of drugs and offers an array of clinic optimization services. Fertility lab procedures involve various steps and variables which can impact the overall success rate of IVF treatment. The introduction of cutting-edge fertility technology complements our portfolio and promises to decrease manual labor, increases precision and thus optimizes IVF outcomes for patients in India. Studies say nearly 27.5 million* Indian couples are actively seeking solution for infertility and with this technology are in position to offer them better access to world class treatment” said Anandram Narasimhan, General Manager –India Cluster, Merck Biopharma.

Through the expansion of its portfolio of innovative pharmaceutical and technology products that fulfil unmet medical needs in the field of fertility treatment, Merck is aiming to provide broader range of products to help support Healthcare professionals to optimize treatment outcomes and fulfil the dream of becoming a parent.

With this latest addition to its market-leading IVF drugs and services, Merck offers a comprehensive and holistic portfolio that facilitates IVF outcomes delivered by clinicians and specialists in India.

1 comment:

Aaradhya said...

IUI: Intrauterine insemination, or IUI, basically just gives sperm a little more assistance in getting to an egg than it would through sexual intercourse. It’s typically recommended for couples who have had difficulty conceiving, but no structural or serious infertility problem; alternatively, it might be recommended for couples who require donor sperm

IVF: In-vitro fertilization, or IVF, has been used as a catch-all for all assisted reproduction treatments, but it’s actually a unique procedure aimed to help women with structural obstacles to fertility. A specialist will collect the egg(s), along with a semen sample from the partner or donor. The egg(s) and sperm will be placed in the same laboratory dish until a sperm fertilizes the egg, and the resulting embryo(s) will be transferred into the uterus of the female partner or surrogate

Total Pageviews